Showing results (181-190 of 341) with videos related to
Sort By:
Pageof 35
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1989
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2S Bodmer, K Strommer, K Frei, et al.Clinical Neuropathology|December 9, 2004
Malignant transformation of a spinal cord ganglioglioma--case report and review of the literatureP L Di Patre, M Payer, M Brunea, et al.British Journal of Neurosurgery|January 1, 1989
The implications of the heterogeneous distribution of Ki-67 labelled cells in meningiomasH P Siegers, P Zuber, M F Hamou, et al.Current Opinion in Oncology|March 1, 1993
Immunologic recognition of malignant melanoma by autologous T lymphocytesS Carrel, J P JohnsonJournal of Immunology (Baltimore, Md. : 1950)|May 15, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivoK Frei, D Piani, U V Malipiero, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|March 22, 2000
Childhood epilepsy with neuropsychological regression and continuous spike waves during sleep: epilepsy surgery in a young adultE Roulet Perez, M Seeck, E Mayer, et al.Neuro-Chirurgie|January 1, 1984
[Endovascular treatment of pure spontaneous dural vascular malformations. Review of 23 cases studied and treated between May 1980 and October 1983]P Lasjaunias, P Halimi, L Lopez-Ibor, et al.Journal of Neuroimmunology|March 1, 1994
Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivoM Tada, A C Diserens, I Desbaillets, et al.The Journal of Trauma|September 1, 1988
Plasma pituitary hormone levels in severe trauma with or without head injuryR Chioléro, T Lemarchand, Y Schutz, et al.Pageof 35